{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:40:17Z","timestamp":1739292017184,"version":"3.37.0"},"reference-count":262,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:00:00Z","timestamp":1248998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1111\/j.1365-2133.2009.09395.x","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T11:18:25Z","timestamp":1249039105000},"page":"12-21","source":"Crossref","is-referenced-by-count":5,"title":["Report from the 67th Annual Meeting of the American Academy of Dermatology"],"prefix":"10.1093","volume":"162","author":[{"given":"A.B.","family":"Alexandroff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.C.","family":"Graham-Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,7,31]]},"reference":[{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB1|cit1","first-page":"597","article-title":"Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level","volume":"159","author":"Nowecki","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2133.2008.08709.x","article-title":"Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1\/Th2 balance in patients with metastatic melanoma","volume":"159","author":"Green","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2006.07664.x","article-title":"Phase I\/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma","volume":"156","author":"Green","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB4|cit4","first-page":"669","article-title":"Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting","volume":"159","author":"Vestergaard","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2133.2008.08681.x","article-title":"Melanoma histological Breslow thickness predicted by 75-MHz ultrasonography","volume":"159","author":"Guitera","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2008.08501.x","article-title":"Dermoscopy of fully regressive cutaneous melanoma","volume":"158","author":"Bories","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2133.2008.08687.x","article-title":"Dermoscopy of desmoplastic melanoma: report of six cases","volume":"159","author":"Debarbieux","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2133.2007.07937.x","article-title":"Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection","volume":"157","author":"Debarbieux","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2133.2008.08675.x","article-title":"\u2018Autoimmunity\u2019 is not always associated with prolonged survival in melanoma patients","volume":"159","author":"Pfohler","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2133.2008.08641.x","article-title":"An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5\u2003mm thick at diagnosis","volume":"159","author":"Einwachter-Thompson","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2008.08649.x","article-title":"Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols","volume":"159","author":"Argenziano","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2133.2007.08389.x","article-title":"In vivo confocal laser scanning microscopy of melanocytic skin tumours: diagnostic applicability using unselected tumour images","volume":"158","author":"Gerger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2133.2007.08404.x","article-title":"Complex dermoscopic pattern: a potential risk marker for melanoma","volume":"158","author":"Lipoff","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2133.2007.08324.x","article-title":"Use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma","volume":"158","author":"Hall","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB15|cit15","first-page":"88","article-title":"Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors","volume":"158","author":"Tao","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1365-2133.2007.08246.x","article-title":"Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma","volume":"157","author":"Tucci","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2007.08168.x","article-title":"Can automated dermoscopy image analysis instruments provide added benefit for the dermatologist? A study comparing the results of three systems","volume":"157","author":"Perrinaud","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2133.2007.08145.x","article-title":"The significance of multiple blue-grey dots (granularity) for the dermoscopic diagnosis of melanoma","volume":"157","author":"Braun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.2007.08136.x","article-title":"A retrospective study addressed to understanding what predicts severe histological dysplasia\/early melanoma in excised atypical melanocytic lesions","volume":"157","author":"Strauss","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2133.2007.07960.x","article-title":"Sunbeds, beauty and melanoma","volume":"157","author":"Diffey","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2133.2007.08029.x","article-title":"Trends in melanoma epidemiology suggest three different types of melanoma","volume":"157","author":"Lipsker","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2133.2007.08031.x","article-title":"Acral lentiginous melanoma: histopathological prognostic features of 121 cases","volume":"157","author":"Phan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.2007.08042.x","article-title":"Treatment of lentigo maligna with topical 1% cidofovir","volume":"157","author":"Calista","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2133.2007.08016.x","article-title":"Does spontaneous autoimmunity improve survival in visceral metastatic melanoma?","volume":"157","author":"Vercambre-Darras","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-2133.2007.07932.x","article-title":"The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic","volume":"156","author":"Haniffa","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2133.2006.07570.x","article-title":"Melanomas arising from naevi and de novo melanomas: does origin matter?","volume":"156","author":"Weatherhead","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2133.2007.07924.x","article-title":"Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and Spitzoid lesion","volume":"156","author":"Takata","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2133.2006.07737.x","article-title":"Ultraviolet B exposure could influence the interpretation of serum S100beta levels in patients with malignant melanoma","volume":"156","author":"Vitzthum","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2133.2006.07678.x","article-title":"Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma","volume":"156","author":"Kawasaki","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1365-2133.2007.07821.x","article-title":"Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment","volume":"156","author":"Meier","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2133.2007.07805.x","article-title":"Factors associated with a high tumour thickness in patients with melanoma","volume":"156","author":"Baumert","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2133.2006.07581.x","article-title":"Expression of p16, CD95, CD95L and Helix pomatia agglutinin in relapsing and nonrelapsing very thin melanoma","volume":"156","author":"Fearfield","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2133.2006.07645.x","article-title":"p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants","volume":"156","author":"Stefanaki","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2133.2006.07567.x","article-title":"Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study","volume":"156","author":"Brown","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.2006.07537.x","article-title":"The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index","volume":"156","author":"Odenbro","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2133.2007.08316.x","article-title":"Genetics of melanoma tumorigenesis","volume":"158","author":"Singh","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2008.08688.x","article-title":"Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells","volume":"159","author":"Boulaiz","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2133.2008.08682.x","article-title":"Genetics of melanoma predisposition","volume":"159","author":"Lin","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB39|cit39","first-page":"243","article-title":"Molecular alterations at chromosome 9p21 in melanocytic naevi and melanoma","volume":"158","author":"Sini","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB40|cit40","first-page":"162","article-title":"Skin deep: report from the annual meeting of the British Society for Investigative Dermatology","volume":"29","author":"Alexandroff","year":"2007","journal-title":"Exp Oncol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB41|cit41","first-page":"411","article-title":"Constitutive activation of the phosphatidyl inositol 3 kinase signalling pathway in acral lentiginous melanoma","volume":"158","author":"Muchemwa","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0161-5890(00)00079-1","article-title":"Role for CD40-CD40 ligand interactions in the immune response to solid tumours","volume":"37","author":"Alexandroff","year":"2000","journal-title":"Mol Immunol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB43|cit43","first-page":"4","article-title":"Understanding Spitzoid tumours: new insights from molecular pathology","volume":"158","author":"Da Forno","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB44|cit44","doi-asserted-by":"crossref","DOI":"10.1586\/edm.09.15","article-title":"Lack of significance of sentinel lymph node biopsy for the prognosis and management of the atypical Spitz tumor of uncertain biologic potential","author":"Alexandroff","year":"2009","journal-title":"Expert Rev Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.2007.08120.x","article-title":"C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay","volume":"157","author":"Lugassy","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-5699(98)01265-1","article-title":"Tumour immunology: false hopes - new horizons?","volume":"19","author":"Alexandroff","year":"1998","journal-title":"Immunol Today"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/bjc.1998.300","article-title":"Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer","volume":"77","author":"Alexandroff","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002620050330","article-title":"Once more unto the breach. Inaugural meeting of the British Society for Immunology Tumour Immunology Affinity Group","volume":"43","author":"Alexandroff","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB49|cit49","first-page":"524","article-title":"Cancer biologists hit the road. Molecular genetics of cancer: Second Joint Conference of the American Association for Cancer Research and the European Association for Cancer Research","volume":"3","author":"Alexandroff","year":"1997","journal-title":"Mol Med Today"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.2007.07972.x","article-title":"Proposal of a new classification system for melanocytic naevi","volume":"157","author":"Argenziano","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2133.2008.08775.x","article-title":"Complications of congenital melanocytic naevi in children: analysis of 16\u2003years\u2019 experience and clinical practice","volume":"159","author":"Kinsler","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2133.2008.08460.x","article-title":"In vivo confocal scanning laser microscopy of common naevi with globular, homogeneous and reticular pattern in dermoscopy","volume":"158","author":"Ahlgrimm-Siess","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1365-2133.2007.08062.x","article-title":"Giant bathing trunk naevus with lymphadenopathy and unusual pathology","volume":"157","author":"West","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1365-2133.2007.07915.x","article-title":"Rapid, severe repigmentation of congenital melanocytic naevi after curettage and dermabrasion: histological features","volume":"156","author":"Kishi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2133.2008.08849.x","article-title":"Great Ormond Street Hospital for Children Registry for Congenital Melanocytic Naevi: prospective study 1988-2007. Part 1 - epidemiology, phenotype and outcomes","volume":"160","author":"Kinsler","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2133.2008.08901.x","article-title":"Great Ormond Street Hospital for Children Registry for Congenital Melanocytic Naevi: prospective study 1988-2007. Part 2 - evaluation of treatments","volume":"160","author":"Kinsler","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2133.2008.08656.x","article-title":"Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren","volume":"159","author":"Gallus","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.2007.08057.x","article-title":"Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases","volume":"157","author":"Mourmouras","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2133.2007.07998.x","article-title":"Leptomeningeal melanoma and multiple cutaneous melanocytic naevi","volume":"157","author":"Ponnampalam","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2133.2005.06973.x","article-title":"Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi","volume":"154","author":"Zalaudek","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2133.2008.08510.x","article-title":"Dermoscopic patterns of naevi in fifth grade children of the Framingham school system","volume":"158","author":"Scope","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/archderm.137.12.1583","article-title":"Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions","volume":"137","author":"Menzies","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2133.2006.07452.x","article-title":"The PRIDE (Papulopustules and\/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome","volume":"155","author":"Lacouture","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.1365-2133.2006.07519.x","article-title":"Erlotinib-associated skin reactions: case report and proposal for classification","volume":"155","author":"Zoller","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-2133.2008.08547.x","article-title":"Palliative therapy of giant basal cell carcinoma with the monoclonal antiepidermal growth factor receptor antibody cetuximab","volume":"158","author":"Muller","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2133.2006.07299.x","article-title":"Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?","volume":"155","author":"Wierzbicka","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1634\/theoncologist.2008-0149","article-title":"Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy","volume":"13","author":"Jatoi","year":"2008","journal-title":"Oncologist"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/cncr.23621","article-title":"Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB)","volume":"113","author":"Jatoi","year":"2008","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(09)60569-9","article-title":"Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial","volume":"373","author":"Pirker","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2005.09.002","article-title":"Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer","volume":"51","author":"Dudek","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3892\/or_00000319","article-title":"Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis","volume":"21","author":"Orditura","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.bjc.6604983","article-title":"Cetuximab plus gemcitabine\/oxaliplatin (GEMOXCET) in first-line metastatic pancreatic cancer: a multicentre phase II study","volume":"100","author":"Kullmann","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3816\/CCC.2008.n.040","article-title":"Completeness in the reporting of dermatologic adverse drug reactions associated with monoclonal antibody epidermal growth factor receptor inhibitors in phase II and III colorectal cancer clinical trials","volume":"7","author":"Bauer","year":"2008","journal-title":"Clin Colorectal Cancer"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2005.07010.x","article-title":"Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab","volume":"154","author":"Shu","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jpainsymman.2006.07.006","article-title":"Efficacy of pregabalin in the management of cetuximab-related itch","volume":"32","author":"Porzio","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.2006.06201.x","article-title":"Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?","volume":"134","author":"Gerecitano","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2008.08680.x","article-title":"A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index","volume":"159","author":"Berth-Jones","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2133.2008.08889.x","article-title":"Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis","volume":"160","author":"Henno","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2008.08890.x","article-title":"Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model","volume":"160","author":"Stenderup","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2133.2008.08863.x","article-title":"Economic evaluation of etanercept in the management of chronic plaque psoriasis","volume":"160","author":"Lloyd","year":"2009","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2009.09395.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2133.2008.08781.x","article-title":"Long-term data in the treatment of psoriasis","volume":"159","author":"Thaci","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2133.2008.08737.x","article-title":"BAFF is elevated in serum of patients with psoriasis: association with disease activity","volume":"159","author":"Samoud-El","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.2008.08727.x","article-title":"Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis","volume":"159","author":"Feldman","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2133.2008.08728.x","article-title":"Review and expert opinion on prevention and treatment of infliximab-related infusion reactions","volume":"159","author":"Lecluse","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2008.08729.x","article-title":"Analysis of 3-year national reimbursement application data on etanercept and efalizumab for psoriasis","volume":"159","author":"Driessen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB89|cit89","first-page":"426","article-title":"Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists","volume":"159","author":"Wakkee","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2133.2008.08686.x","article-title":"Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study","volume":"159","author":"Rigopoulos","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.2008.08627.x","article-title":"Beta-papillomaviruses and psoriasis: an intrapatient comparison of human papillomavirus carriage in skin and hair","volume":"159","author":"Cronin","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2133.2008.08628.x","article-title":"Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis","volume":"159","author":"Strober","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2133.2008.08606.x","article-title":"Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis","volume":"159","author":"Nijsten","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2008.08608.x","article-title":"Increased vessel density in psoriasis: involvement of lymphatic vessels in the papillary dermis","volume":"159","author":"Fiedler","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.2008.08618.x","article-title":"Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies","volume":"159","author":"Van Lingen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.2008.08578.x","article-title":"Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis","volume":"159","author":"Simon","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1365-2133.2008.08515.x","article-title":"CD26\/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes","volume":"158","author":"Van Lingen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2133.2008.08505.x","article-title":"The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance","volume":"158","author":"Chen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2133.2008.08508.x","article-title":"Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells","volume":"158","author":"Farkas","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1365-2133.2008.08513.x","article-title":"Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin","volume":"158","author":"Oh","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2133.2008.08504.x","article-title":"Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides","volume":"158","author":"Fujimura","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1365-2133.2008.08482.x","article-title":"Polymorphisms in the PTPN22 region are associated with psoriasis of early onset","volume":"158","author":"Smith","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2133.2008.08442.x","article-title":"Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression","volume":"158","author":"Vissers","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1365-2133.2008.08470.x","article-title":"New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra","volume":"158","author":"Gonzalez-Lopez","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2133.2008.08440.x","article-title":"Adalimumab: a new alternative biologic agent for chronic plaque psoriasis","volume":"158","author":"Ormerod","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2133.2007.08417.x","article-title":"Follow-up analysis of 180 Chinese Han families: identification of a novel locus for psoriasis at 2p22.3-11.2","volume":"158","author":"Sun","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2133.2007.08426.x","article-title":"Methotrexate: prescribing and monitoring practices among the consultant membership of the British Association of Dermatologists","volume":"158","author":"Collin","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2133.2007.08393.x","article-title":"Antilymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells","volume":"158","author":"Ardern-Jones","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08377.x","article-title":"Telomerase activity in peripheral blood mononuclear cells of psoriatic patients correlates with disease severity","volume":"158","author":"Liu","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2007.08334.x","article-title":"C-reactive protein in psoriasis","volume":"158","author":"Sergeant","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2133.2007.08337.x","article-title":"A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting","volume":"158","author":"De Korte","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2133.2007.08338.x","article-title":"Inpatient management of psoriasis: a multicentre service review to establish national admission standards","volume":"158","author":"Woods","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.2007.08236.x","article-title":"Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis","volume":"158","author":"Revicki","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2133.2007.08307.x","article-title":"Explaining phenotype heterogeneity in patients with psoriasis","volume":"158","author":"Christophers","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2007.08333.x","article-title":"Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate","volume":"158","author":"Teraki","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB117|cit117","first-page":"138","article-title":"Alcohol consumption and psychological distress in patients with psoriasis","volume":"158","author":"Kirby","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB118|cit118","first-page":"116","article-title":"Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial","volume":"158","author":"Flytstrom","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","article-title":"Comparison of cutaneous tolerance and efficacy of calcitriol 3\u2003\u03bcg g-1 ointment and tacrolimus 0.3\u2003mg g-1 ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial","volume":"157","author":"Liao","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1365-2133.2007.08195.x","article-title":"Increased nuclear beta-catenin in suprabasal involved psoriatic epidermis","volume":"157","author":"Hampton","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1365-2133.2007.08200.x","article-title":"CTACK \/CCL27 expression in psoriatic skin and its modification after administration of etanercept","volume":"157","author":"Campanati","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2133.2007.08205.x","article-title":"Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96\u2003weeks","volume":"157","author":"Krishnan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2007.08209.x","article-title":"Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy","volume":"157","author":"Smith","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1365-2133.2007.08185.x","article-title":"Differentiation of tumour-stage mycosis fungoides, psoriasis vulgaris and normal controls in a pilot study using serum proteomic analysis","volume":"157","author":"Cowen","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1365-2133.2007.08148.x","article-title":"Psoriasis and psoriatic arthritis: separate or one and the same?","volume":"157","author":"Ciocon","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2133.2007.08135.x","article-title":"Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research","volume":"157","author":"Guttman-Yassky","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB127|cit127","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2133.2007.08111.x","article-title":"Infliximab, as sole or combined therapy, induces rapid clearing of erythrodermic psoriasis","volume":"157","author":"Takahashi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2133.2007.08090.x","article-title":"Quantitative analysis of Malassezia in the scale of patients with psoriasis using a real-time polymerase chain reaction assay","volume":"157","author":"Takahata","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2133.2007.08022.x","article-title":"Reverse transcriptase activity in human normal and psoriatic skin samples","volume":"157","author":"Moles","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2133.2007.08039.x","article-title":"Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1","volume":"157","author":"Watabe","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2133.2007.08052.x","article-title":"Recalcitrant lithium-induced psoriasis in a suicidal patient alleviated by tumour necrosis factor-alpha inhibition","volume":"157","author":"Wachter","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2007.07928.x","article-title":"Successful treatment of severe psoriatic arthritis with infliximab in an 11-year-old child suffering from linear psoriasis along lines of Blaschko","volume":"157","author":"Rott","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2133.2007.07999.x","article-title":"On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis","volume":"157","author":"Hoffjan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2133.2007.07988.x","article-title":"Consecutive use of different biological therapies in the treatment of psoriasis","volume":"157","author":"Costanzo","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2133.2007.07993.x","article-title":"Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population","volume":"157","author":"Nedoszytko","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1365-2133.2007.07906.x","article-title":"Family history of psoriasis and age at disease onset in Italian patients with psoriasis","volume":"156","author":"Altobelli","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1365-2133.2007.07935.x","article-title":"Neuropeptides and their receptors in psoriatic skin in relation to pruritus","volume":"156","author":"Chang","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2133.2007.07945.x","article-title":"Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function","volume":"157","author":"Bedini","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2007.07889.x","article-title":"In vivo quantification of microvessels in clinically uninvolved psoriatic skin and in normal skin","volume":"156","author":"Hern","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-2133.2006.07743.x","article-title":"Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy","volume":"156","author":"Komatsu","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2133.2007.07776.x","article-title":"Allergic contact dermatitis complicating pustular psoriasis in two patients","volume":"156","author":"Katugampola","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-2133.2007.07820.x","article-title":"Cytokine gene polymorphisms in Chinese patients with psoriasis","volume":"156","author":"Chang","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2133.2007.07779.x","article-title":"Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT\/enhancer binding protein beta in activated human T cells","volume":"156","author":"Gerdes","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2006.07642.x","article-title":"Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis","volume":"156","author":"Peltonen","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1365-2133.2008.08568.x","article-title":"Updates from the British Association of Dermatologists 87th annual meeting","volume":"158","author":"Birnie","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2133.2007.07761.x","article-title":"Updates from the British Association of Dermatologists 86th annual meeting, 4-7 July 2006, Manchester, U.K","volume":"156","author":"Birnie","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2133.2006.07716.x","article-title":"Association between the insertion\/deletion polymorphism of the angiotensin I-converting enzyme gene and risk for psoriasis in a Chinese population in Taiwan","volume":"156","author":"Chang","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","article-title":"Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet","volume":"156","author":"Michaelsson","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-2133.2006.07731.x","article-title":"Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis","volume":"156","author":"Kingo","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2133.2006.07629.x","article-title":"Psoriasis after cord blood stem cell transplantation","volume":"156","author":"Hubiche","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2006.07602.x","article-title":"Severe psoriasis treated with a new macrolide: everolimus","volume":"156","author":"Frigerio","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2006.07628.x","article-title":"Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy","volume":"156","author":"Hochberg","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.2006.07660.x","article-title":"Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study","volume":"156","author":"Bovenschen","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2133.2006.07675.x","article-title":"A classification of psoriasis vulgaris according to phenotype","volume":"156","author":"Griffiths","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.2006.07641.x","article-title":"Transglutaminase inhibitors induce hyperproliferation and parakeratosis in tissue-engineered skin","volume":"156","author":"Harrison","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2133.2006.07561.x","article-title":"A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation","volume":"156","author":"Korver","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2133.2006.07573.x","article-title":"T cell\/keratinocyte interactions in psoriasis: where is the trigger?","volume":"156","author":"Simonart","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2133.2007.07817.x","article-title":"The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis","volume":"156","author":"Katugampola","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2133.2008.08732.x","article-title":"Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials","volume":"159","author":"Schmitt","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.2007.08025.x","article-title":"Inhibition of tumour necrosis factor-alpha secretion from EpiDermTM tissues by a novel small molecule, UTL-5d","volume":"157","author":"Shaw","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2133.2008.08669.x","article-title":"Etanercept combined with methotrexate for high-need psoriasis","volume":"159","author":"Driessen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2133.2006.07571.x","article-title":"Differential clinical response to alefacept in combination with methotrexate in two patients with refractory palmar psoriasis","volume":"156","author":"Jacobi","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2009.09395.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2007.07762.x","article-title":"Efalizumab in routine use: a clinical experience","volume":"156","author":"Selenko-Gebauer","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2133.2008.08865.x","article-title":"Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre","volume":"160","author":"Warren","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB168|cit168","first-page":"329","article-title":"308\u2003nm monochromatic excimer light in dermatology: personal experience and review of the literature","volume":"143","author":"Mavilia","year":"2008","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0781.2006.00232.x","article-title":"Effective treatment of scalp psoriasis using the excimer (308\u2003nm) laser","volume":"22","author":"Morison","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/1523-1747.ep12464137","article-title":"Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment","volume":"91","author":"Stern","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1056\/NEJM197304262881715","article-title":"Occlusive vascular disease in psoriatic patients","volume":"288","author":"McDonald","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB172|cit172","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.2009.09281.x","article-title":"More than skin deep: atherosclerosis as a systemic manifestation of psoriasis","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2006.07.011","article-title":"Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients","volume":"190","author":"Wakkee","year":"2007","journal-title":"Atherosclerosis"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2009.09395.x-BIB174|cit174","article-title":"Treating psoriasis as a chronic inflammatory systemic disease","volume":"159","author":"Katsambas","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB175|cit175","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1365-2133.2008.08759.x","article-title":"Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis","volume":"159","author":"Kaur","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB176|cit176","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.2007.08068.x","article-title":"Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review","volume":"157","author":"Sterry","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB177|cit177","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2007.08.006","article-title":"Comorbidities in psoriasis","volume":"25","author":"Christophers","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB178|cit178","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB179|cit179","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB180|cit180","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB181|cit181","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2008.08707.x","article-title":"Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis","volume":"159","author":"Kaye","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB182|cit182","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjcard.2008.10.004","article-title":"AJC editor\u2019s consensus: psoriasis and coronary artery disease","volume":"102","author":"Friedewald","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB183|cit183","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1365-2133.2008.08814.x","article-title":"Psoriasis and the risk of incident diabetes mellitus: a population-based study","volume":"159","author":"Brauchli","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB184|cit184","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2133.2008.09020.x","article-title":"Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis","volume":"160","author":"Brauchli","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB185|cit185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.2009.09395.x-BIB186|cit186","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2133.2008.08779.x","article-title":"Long-term prognosis in patients with psoriasis","volume":"159","author":"Gulliver","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB187|cit187","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2133.2009.09107.x","article-title":"Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology","volume":"160","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB188|cit188","first-page":"382","article-title":"IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of \u2018psoriatic nephropathy\u2019","volume":"19","author":"Zadrazil","year":"2006","journal-title":"J Nephrol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB189|cit189","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1159\/000119716","article-title":"Mesangial proliferative glomerulonephritis with or without IgA deposits: the morphological characters in psoriasis vulgaris","volume":"108","author":"Jiao","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB190|cit190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajo.2004.08.053","article-title":"Psoriatic uveitis: a distinct clinical entity?","volume":"139","author":"Durrani","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB191|cit191","first-page":"83","volume-title":"Psoriasis","author":"Friedlaender","year":"1991"},{"volume-title":"Trends in Dermatology Research","year":"2010","author":"Alexandroff","key":"10.1111\/j.1365-2133.2009.09395.x-BIB192|cit192"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB193|cit193","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB194|cit194","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaad.2004.06.017","article-title":"Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis","volume":"52","author":"Prodanovich","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB195|cit195","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/01.CIR.0000142864.83780.81","article-title":"Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis","volume":"110","author":"Krishnan","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB196|cit196","doi-asserted-by":"crossref","first-page":"384","DOI":"10.7861\/clinmedicine.8-4-384","article-title":"Cardiovascular disease - the silent killer in rheumatoid arthritis","volume":"8","author":"Kumar","year":"2008","journal-title":"Clin Med"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB197|cit197","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1478271520083802004","article-title":"\u2018Non solum...sed etiam\u2019: added cardiac benefits of TNF alpha blockade in rheumatoid arthritis","volume":"38","author":"Raftery","year":"2008","journal-title":"J R Coll Physicians Edin"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB198|cit198","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2133.2009.09038.x","article-title":"Prevalence and molecular characteristics of Staphylococcus aureus isolates colonizing patients with atopic dermatitis and their close contacts in Singapore","volume":"160","author":"Chiu","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB199|cit199","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2133.2008.08905.x","article-title":"Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis","volume":"160","author":"Warner","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB200|cit200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2133.2007.08197.x","article-title":"Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo","volume":"157","author":"Durupt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB201|cit201","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2008.08612.x","article-title":"Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and S\u00e9zary syndrome","volume":"159","author":"Talpur","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB202|cit202","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1365-2133.2008.08817.x","article-title":"Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization","volume":"159","author":"Kedzierska","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB203|cit203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijantimicag.2005.11.004","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus infections","volume":"27","author":"Maltezou","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB204|cit204","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sder.2006.04.005","article-title":"Community-acquired methicillin resistant Staphylococcus aureus skin infection","volume":"25","author":"Halem","year":"2006","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB205|cit205","first-page":"14","article-title":"Community acquired MRSA. Expert opinion","volume":"4","author":"Alexandroff","year":"2008","journal-title":"MIMS Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB206|cit206","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1371\/journal.pone.0003198","article-title":"Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis","volume":"3","author":"Diep","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB207|cit207","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/345436","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors","volume":"36","author":"Salgado","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB208|cit208","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/JCM.43.5.2384-2390.2005","article-title":"Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease","volume":"43","author":"Holmes","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB209|cit209","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2807\/esm.11.01.00594-en","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland: first surveillance report","volume":"11","author":"Aramburu","year":"2006","journal-title":"Euro Surveill"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB210|cit210","first-page":"335","article-title":"Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the community","volume":"40","author":"Lee","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB211|cit211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkm410","article-title":"Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis","volume":"61","author":"Millar","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB212|cit212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/IOP.0b013e318192a29b","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus periorbital cellulitis: a problem here to stay","volume":"25","author":"Goldstein","year":"2009","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB213|cit213","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1086\/522171","article-title":"Fatal brain abscess due to community-associated methicillin-resistant Staphylococcus aureus strain USA300","volume":"45","author":"Sifri","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB214|cit214","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1542\/peds.2004-2300","article-title":"Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus","volume":"115","author":"Gonzalez","year":"2005","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB215|cit215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1086\/432475","article-title":"Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection","volume":"41","author":"Gonzalez","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB216|cit216","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJMclde0708359","article-title":"Clinical decisions. Management of skin and soft-tissue infection","volume":"359","author":"Chambers","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB217|cit217","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1503\/cmaj.071812","article-title":"Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection","volume":"179","author":"Dial","year":"2008","journal-title":"CMAJ"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB218|cit218","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0378-6323.38431","article-title":"Clinical study of cutaneous drug eruptions in 200 patients","volume":"74","author":"Raksha","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB219|cit219","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"issue":"pii","key":"10.1111\/j.1365-2133.2009.09395.x-BIB220|cit220","article-title":"EUREGIO MRSA-net Twente\/Munsterland - a Dutch-German cross-border network for the prevention and control of infections caused by methicillin-resistant Staphylococcus aureus","volume":"13","author":"Friedrich","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB221|cit221","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/JCM.43.4.2034-2035.2005","article-title":"Successful search-and-destroy policy for methicillin-resistant Staphylococcus aureus in The Netherlands","volume":"43","author":"Vos","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB222|cit222","first-page":"CD003340","article-title":"Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization","volume":"4","author":"Loeb","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB223|cit223","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2133.2008.09018.x","article-title":"Effect of transdermal botulinum toxin on sweat secretion in subjects with idiopathic palmar hyperhidrosis","volume":"160","author":"Chow","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB224|cit224","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1365-2133.2008.08476.x","article-title":"Topical glycopyrrolate for patients with facial hyperhidrosis","volume":"158","author":"Kim","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB225|cit225","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2133.2007.08092.x","article-title":"Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective","volume":"157","author":"Bechara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB226|cit226","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2133.2007.07884.x","article-title":"Use of oral glycopyrronium bromide in hyperhidrosis","volume":"157","author":"Bajaj","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB227|cit227","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.2007.07691.x","article-title":"Needle-free anaesthesia prior to botulinum toxin type A injection treatment of palmar and plantar hyperhidrosis","volume":"156","author":"Benohanian","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB228|cit228","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-2133.2007.07760.x","article-title":"Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study","volume":"156","author":"Vadoud-Seyedi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB229|cit229","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2133.2006.07637.x","article-title":"Surgical treatment of axillary hyperhidrosis","volume":"156","author":"Bechara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB230|cit230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0738-081X(02)00330-9","article-title":"Dyes in dermatology","volume":"21","author":"Balabanova","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB231|cit231","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.2007.08087.x","article-title":"Community-based study of acne vulgaris in adolescents in Singapore","volume":"157","author":"Tan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB232|cit232","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2133.2008.08701.x","article-title":"The changing face of dermatological practice: 25\u2003years\u2019 experience","volume":"159","author":"Benton","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB233|cit233","first-page":"1208","article-title":"Acne successfully treated with acitretin in a patient with peanut allergy. Reply","volume":"159","author":"Walsh","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB234|cit234","first-page":"1086","article-title":"Tissue and blood superoxide dismutase activities and malondialdehyde levels in different clinical severities of acne vulgaris","volume":"159","author":"Abdel Fattah","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB235|cit235","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2008.08764.x","article-title":"Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne","volume":"159","author":"Vora","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB236|cit236","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2007.08308.x","article-title":"A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris","volume":"158","author":"Langner","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB237|cit237","first-page":"208","article-title":"Efficacy of tetracyclines in the treatment of acne vulgaris: a review","volume":"158","author":"Simonart","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB238|cit238","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2133.2007.08250.x","article-title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","volume":"157","author":"Azoulay","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB239|cit239","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2133.2007.08172.x","article-title":"Infliximab-induced acne: report of a third case","volume":"158","author":"Sladden","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB240|cit240","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2133.2007.08074.x","article-title":"Photodynamic therapy of acne using methyl aminolaevulinate diluted to 4% together with low doses of red light","volume":"157","author":"Mavilia","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB241|cit241","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2133.2007.08083.x","article-title":"Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris","volume":"157","author":"Charakida","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB242|cit242","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2007.07896.x","article-title":"Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study","volume":"157","author":"Verfaille","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB243|cit243","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2133.2006.07631.x","article-title":"Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes","volume":"156","author":"Wilcox","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB244|cit244","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.2006.07517.x","article-title":"Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne","volume":"156","author":"Mourelatos","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB245|cit245","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2133.2009.09047.x","article-title":"Laser and other light therapies for the treatment of acne vulgaris: systematic review","volume":"160","author":"Hamilton","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB246|cit246","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1365-2133.2009.09054.x","article-title":"The practicalities of photodynamic therapy in acne vulgaris","volume":"160","author":"Taylor","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB247|cit247","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.2008.08959.x","article-title":"Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris","volume":"160","author":"Ganceviciene","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB248|cit248","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2133.2008.08819.x","article-title":"Outcome measures in acne vulgaris: systematic review","volume":"160","author":"Barratt","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB249|cit249","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2133.2008.08935.x","article-title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","volume":"160","author":"Layton","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB250|cit250","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","article-title":"Guidelines for topical photodynamic therapy: update","volume":"159","author":"Morton","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB251|cit251","first-page":"1209","article-title":"Low frequency of acne vulgaris in adolescent girls and women with Turner\u2019s syndrome: a clinical, genetic and hormonal study of 65 patients","volume":"159","author":"Brazzelli","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB252|cit252","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2133.2008.08635.x","article-title":"The chemistry and synergy of benzoyl peroxide with clindamycin","volume":"159","author":"Burkhart","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB253|cit253","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2133.2008.08597.x","article-title":"Acne successfully treated with acitretin in a patient with peanut allergy","volume":"159","author":"Laing","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB254|cit254","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1365-2133.2008.08559.x","article-title":"Unilateral segmental acneiform naevus: a model disorder towards understanding fibroblast growth factor receptor 2 function in acne?","volume":"158","author":"Melnik","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB255|cit255","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.2007.08399.x","article-title":"Pitfalls of prescribing acne therapies including isotretinoin for pilots","volume":"158","author":"Taibjee","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB256|cit256","first-page":"201","article-title":"Linoleic and linolenic acids and acne vulgaris","volume":"158","author":"Logan","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB257|cit257","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archderm.138.12.1584","article-title":"Acne vulgaris: a disease of Western civilization","volume":"138","author":"Cordain","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB258|cit258","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaad.2004.09.022","article-title":"Acne and milk, the diet myth, and beyond","volume":"52","author":"Danby","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB259|cit259","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3181\/00379727-146-38103","article-title":"Progesterone concentration in milk and blood during pregnancy in cows","volume":"146","author":"Ginther","year":"1974","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB260|cit260","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/vr.94.8.160-a","article-title":"Proceedings. Pregnancy diagnosis in cows: use of progestagen concentration in milk","volume":"94","author":"Heap","year":"1974","journal-title":"Vet Rec"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB261|cit261","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01525472","article-title":"Natural occurrence of progesterone in commercial milk products (author\u2019s transl)","volume":"158","author":"Hoffmann","year":"1975","journal-title":"Z Lebensm Unters Forsch"},{"key":"10.1111\/j.1365-2133.2009.09395.x-BIB262|cit262","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2527\/jas1976.421155x","article-title":"Factors affecting progesterone concentration in cow\u2019s milk and dairy products","volume":"42","author":"Ginther","year":"1976","journal-title":"J Anim Sci"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09395.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09395.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09395.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:53:20Z","timestamp":1739289200000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/1\/12\/6642531"}},"subtitle":["Report of the 67th Annual Meeting of the AAD"],"short-title":[],"issued":{"date-parts":[[2009,7,31]]},"references-count":262,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09395.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"type":"print","value":"0007-0963"}],"subject":[],"published":{"date-parts":[[2009,7,31]]}}}